I DERM PHARMA

The project addresses a significant unmet need in the psoriasis treatment market by offering a novel, safe, and effective oral treatment. Currently, available therapies either have low efficacy or present considerable safety concerns. For instance, A

I-Derm develops a new nonsteroidal topical treatment for inflammatory skin diseases, based on a novel mechanism of action. This mechanism directly targets cutaneous elements rather than the immune system and is therefore uniquely function only on the skin.

Dermatologists, People with inflammatory skin diseases.

Sharon Navon - CEO & Co-Founder